ENTITY

Immuno Cure BioTech (2163385D CH)

1
Analysis
Health CareHong Kong
Immuno Cure BioTech Limited medical technology development businesses. The Company develops gene vaccines, antibody drugs, and other products. Immuno Cure BioTech conducts businesses in China and Hong Kong.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x